The Sternal Closure Systems Market is steadily growing as the number of cardiac and thoracic surgeries—such as median sternotomy—increases worldwide. These systems, including rigid fixation plates, screws, cables, and bone cement, are designed to stabilize the breastbone after open-chest surgery, promoting healing and reducing complications. Titanium dominates the material segment due to its strength, biocompatibility, and MRI compatibility, while emerging polymers like PEEK are gaining traction for their lightweight and radiolucent properties. North America leads the market, supported by high surgical volume and early adoption of advanced fixation technologies, while Asia-Pacific is delivering the fastest growth driven by expanding healthcare infrastructure and rising demand for cardiac procedures. Market expansion is supported by technological innovation, patient-centric surgical protocols, and greater awareness among clinicians about the benefits of rigid fixation over traditional wire closure.
According to Fortune Business Insights, the global sternal closure systems market size was valued at USD 1.98 billion in 2024. The market is projected to grow from USD 2.10 billion in 2025 to USD 3.13 billion by 2032, exhibiting a CAGR of 5.9% during the 2025–2032 period. North America dominated the sternal closure systems market with a market share of 45.23% in 2024.
In June 2021, Able Medical Devices rolled out the Valkyrie Thoracic Fixation System—the first single‑use, radiolucent plating system specifically designed to span osteotomies and secure sternums after open‑heart surgery. This move signals a shift toward disposable, image‑friendly stabilization technologies.